课题基金 / 基金详情

Alzheimer's disease-specific extracellular vesicles: from pathology to novel biomarker discovery

Alzheimer's disease-specific extracellular vesicles: from pathology to novel biomarker discovery
阿尔茨海默病特异性细胞外囊泡:从病理学到新生物标志物的发现
批准号:
10739392
负责人:
Vasiliki Machairaki
金额:
$239.96万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-01 至 2026-08-31

项目摘要

项目成果

Vasiliki Machairaki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT Alzheimer’s disease (AD) is one of the most devastating neurological diseases characterized by progressive cognitive impairments, including memory loss. The mechanisms of disease progression are not yet fully elucidated, and to date there are no reliable biomarkers for early detection of pathogenic components. Improved capabilities to assess central nervous system brain health with peripheral biofluid samples (Liquid Biopsy) will expand clinical options at all stages of disease. Extracellular vesicles (EVs) of brain origin (bdEVs) cross biological barriers and can be traced back to specific parent cell types suggesting novel diagnostic, prognostic, and monitoring tools, revolutionizing identification and care of AD as well as understanding pathogenesis. bdEVs carry cargos involved in neurotransmission or neuroprotection and facilitate communication between brain cells also making them “targetable agents” of pathology. To lay the groundwork for more efficient peripheral bdEV studies, we have compared the protein content of brain homogenates with purified EV fractions of control and late-stage AD brains. Proteome differences were most pronounced in EVs, while certain cells release more EVs or EVs with higher density of cell-specific surface markers. Based on these novel findings, we propose to use human induced pluripotent stem cell (hiPSC) models of neurons, astrocytes and microglia to test the specificity and sensitivity of the top CNS surface markers we identified in our preliminary studies as enriched on bdEVs from different cell types and as more abundant in AD patients versus controls (Aim 1). To investigate aging- and neurodegeneration-related proteins and RNAs that were differentially regulated in AD bdEVs, we will study three different sources of EVs, including iPSC-derived progeny (Aim 1), brain tissue (Aim 2), and plasma (Aim 3). We will use the same sources to discover new molecular signatures for disease detection and monitoring.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A personalized medicine approach to the study of monoamine brain systems that underlie the emergence of neuropsychiatric symptoms in person with Alzheimer's disease
  • 批准号:
    9896487
  • 项目类别:
  • 资助金额:
    $45.03万
  • 财政年份:
    2020
  • 负责人:
    Vasiliki Machairaki
  • 依托单位:
Novel Approaches to Capture, Sorting, and Characterization of CNS-Origin Extracellular Vesicles
  • 批准号:
    9913760
  • 项目类别:
  • 资助金额:
    $2.06万
  • 财政年份:
    2019
  • 负责人:
    Vasiliki Machairaki
  • 依托单位:
Novel Approaches to Capture, Sorting, and Characterization of CNS-Origin Extracellular Vesicles
  • 批准号:
    10019695
  • 项目类别:
  • 资助金额:
    $75.84万
  • 财政年份:
    2018
  • 负责人:
    Vasiliki Machairaki
  • 依托单位:
Novel Approaches to Capture, Sorting, and Characterization of CNS-Origin Extracellular Vesicles
  • 批准号:
    9789936
  • 项目类别:
  • 资助金额:
    $24.57万
  • 财政年份:
    2018
  • 负责人:
    Vasiliki Machairaki
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: